Skip to content
bob siegerink

bob siegerink

bobsiegerink.com

  • b o b s i e g e r i n k

capita selecta

This website has been moved. Please go to the new website of capita selecta.

  • // Home
  • // Post COVID-19 Functional Status
  • // Research
    • – Preprints
    • – Publications
    • – Shiny apps
  • // Teaching
  • // About me
  • // Contact

Twitter Updates

  • Towards Understanding ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) | Research Square -… twitter.com/i/web/status/1… 9 hours ago
  • RT @JSheltzer: Remember the rumors last year that smoking protects you from COVID? Well, one of the major studies supporting that link was… 18 hours ago
  • brought on my radar by the great @AhmedAAKhalil !!!! 1 day ago
  • RT @Paul_Dirkse: Fantastisch nieuws! Bristol Myers Squibb, één van de grootste biofarmaceutische bedrijven in de wereld, vestigt zich op h… 1 day ago
  • Nightingale, William Farr and the "dual use technology" data visualization - a great podcast. Brought on my radar b… twitter.com/i/web/status/1… 1 day ago
Follow @bobsiegerink

Category Cloud

academia BEMC blog conference fraude grant media meeting methods navigating numbers other publications publishing research science slides stroke teaching thesis
Create a website or blog at WordPress.com